Advertisement China Medical wins SFDA approval for Bladder Cancer FISH Probe - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

China Medical wins SFDA approval for Bladder Cancer FISH Probe

China Medical Technologies, a medical device company, has received approval from the State Food and Drug Administration or SFDA in the People's Republic of China for its Bladder Cancer FISH Probe.

The probe is an advanced molecular diagnostic test kit that uses DNA probes for early detection and monitoring the course of bladder cancer.

It is designed to detect and identify whether aneuploidy for chromosomes three, seven, 17 and loss of the p16 locus are present in the human bladder cells, the company said.